Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Nausea × casopitant × Clear all

Phase

Phase 3 3 Phase 1 2 Phase 2 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 2 Nausea 2

Interventions

casopitant 2 Cyclophosphamide 2 Tablets 1 Methadone 1 Injections, Intravenous 1 Granisetron 1 Dronabinol 1 Docetaxel 1 Cannabidiol 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

GlaxoSmithKline

Phase 1 Terminated

Nausea, Vomiting

NCT00440128 2017-08-04

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

GlaxoSmithKline

Phase 1 Completed

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡